Login
$ZVRA
$9.25 +$0.00 (0.0%) After hours

$ZVRA SEC Filings

Filed On Filing
05 Nov 2026 SCHEDULE 13G/A
03 Nov 2026 10-Q
03 Nov 2026 8-K: Results of Operations and Financial Condition

$37.8 million net revenue for Q3 2026, driven by $34.0 million in revenue from MIPLYFFA

13 Oct 2026 Form 4: McFarlane Neil F., Director

Received 50,000 shares by exercise or conversion · Sold 20,000 shares ($225K)

13 Oct 2026 144
17 Aug 2026 Form 4: Thompson Rahsaan, Chief Legal & Compliance

Sold 42,666 shares ($475K)

14 Aug 2026 144
14 Aug 2026 SCHEDULE 13G/A
12 Aug 2026 Form 4: Watton Corey Michael, Director

Received 12,300 shares by exercise or conversion ($61.1K) · Sold 12,300 shares ($138K)

06 Aug 2026 SCHEDULE 13G/A
05 Aug 2026 10-Q
05 Aug 2026 8-K: Results of Operations and Financial Condition

$39.7 million net revenue for Q2 2026, driven by $30.2 million in revenue from MIPLYFFA

31 Jul 2026 SCHEDULE 13G
08 Jul 2026 144
23 Jun 2026 Form 4: Thompson Rahsaan, Chief Legal & Compliance

Received 66,667 shares by exercise or conversion · Sold 34,557 shares ($438K)

18 Jun 2026 Form 4: Favorito Tamara A, Director

Granted 30,000 Stock Option (right to buy)

18 Jun 2026 Form 4: Secor Alicia, Director

Granted 30,000 Stock Option (right to buy)

18 Jun 2026 Form 4: Watton Corey Michael, Director

Granted 30,000 Stock Option (right to buy)

18 Jun 2026 Form 4: Calder Douglas W, Director

Granted 30,000 Stock Option (right to buy)

18 Jun 2026 Form 4: Anderson Thomas, Director

Granted 30,000 Stock Option (right to buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support